Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Oncology Letters
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-1074 Online ISSN: 1792-1082
Journal Cover
November-2022 Volume 24 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
November-2022 Volume 24 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Concanavalin A inhibits human liver cancer cell migration by regulating F‑actin redistribution and assembly via MAPK signaling pathway

  • Authors:
    • Haoran Jiang
    • Xianxin Wen
    • Xue Zhang
    • Bingyu Zhang
  • View Affiliations / Copyright

    Affiliations: Chongqing Engineering Research Center of Medical Electronics and Information Technology, College of Bioinformatics, Chongqing University of Posts and Telecommunications, Chongqing 400065, P.R. China
    Copyright: © Jiang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 405
    |
    Published online on: September 23, 2022
       https://doi.org/10.3892/ol.2022.13525
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Concanavalin A (Con A), the first and most typical representative of the legume lectin family, has a potent anti‑liver cancer effect by inducing cell apoptosis and autophagy. However, its function in human liver cancer cell migration remains unclear. The present study investigated the effect of Con A on the viability and migration of human liver cancer cells with different metastatic abilities. It was found that Con A could reduce the viability of human liver cancer cells (HCCLM3, MHCC97L and HepG2) and human hepatocytes (MIHA). In addition, Con A could inhibit human liver cancer cell migration specifically without affecting hepatocytes. Sugar inhibition assay showed that glucose‑related sugar binding sites played an important role in the inhibition of Con A on human liver cancer cell migration. In addition, Con A could affect HCCLM3 migration by activating ERK1/2, JNK1/2/3 and p38 signaling in the MAPK pathway. Moreover, Con A could regulate fibrous actin (F‑actin) redistribution and assembly via the MAPK signaling pathway. However, Con A had no significant effect on the activation of matrix metalloproteinase (MMP)‑2 and MMP‑9 in HCCLM3 cells. In conclusion, Con A may bind to glucose‑related receptor protein, activating ERK1/2, JNK1/2/3 and p38 signaling in the MAPK pathway, further contracting cells and reducing the content of F‑actin of single cells to inhibit HCCLM3 cell migration. These results would deepen the links between human liver cancer cell migration and related glycoproteins or signaling molecules, and may provide a new perspective for Con A as a potential anticancer agent.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Figure 7

View References

1 

Yuan H, Ji J, Shi M, Shi Y, Liu J, Wu J, Yang C, Xi W, Li Q, Zhu W, et al: Characteristics of pan-cancer patients with ultrahigh tumor mutation burden. Front Oncol. 11:6820172021. View Article : Google Scholar

2 

Li Y, Zhou Y, Mao F, Shen S, Zhao B, Xu Y, Lin Y, Zhang X, Cao X, Xu Y, et al: mir-452 reverses abnormal glycosylation modification of ERα and estrogen resistance in TNBC (triple-negative breast cancer) through targeting UGT1A1. Front Oncol. 10:15092020. View Article : Google Scholar

3 

Fan C, Tu C, Qi P, Guo C, Xiang B, Zhou M, Li X, Wu X, Li X, Li G, et al: GPC6 promotes cell proliferation, migration, and invasion in nasopharyngeal carcinoma. J Cancer. 10:3926–3932. 2019. View Article : Google Scholar : PubMed/NCBI

4 

Kannagi R: Carbohydrate antigen sialyl Lewis 1- its pathophysiological significance an induction mechanism in cancer progression. Chang Gung Med J. 30:189–209. 2007.PubMed/NCBI

5 

Miyagi T, Takahashi K, Hata K, Shiozaki K and Yamaguchi K: Sialidase significance for cancer progression. Glycoconj J. 29:567–577. 2012. View Article : Google Scholar : PubMed/NCBI

6 

Estrada-Martínez LE, Moreno-Celis U, Cervantes-Jiménez R, Ferriz-Martínez RA, Blanco-Labra A and García-Gasca T: Plant lectins as medical tools against digestive system cancers. Int J Mol Sci. 18:14032017. View Article : Google Scholar

7 

Oliveira I, Nunes A, Lima A, Borralho P, Rodrigues C, Ferreira RB and Ribeiro AC: New lectins from mediterranean flora. Activity against ht29 colon cancer cells. Int J Mol Sci. 20:30592019. View Article : Google Scholar

8 

Lawanprasert A, Guinan CA, Langford EA, Hawkins CE, Sloand JN, Fescemyer HW, Aronson MR, Halle JA, Marden JH and Medina SH: Discovery of antitumor lectins from rainforest tree root transcriptomes. PLoS One. 15:e02294672020. View Article : Google Scholar : PubMed/NCBI

9 

Bloise N, Okkeh M, Restivo E, Della PC and Visai L: Targeting the ‘sweet side’ of tumor with glycan-binding molecules conjugated-nanoparticles: Implications in cancer therapy and diagnosis. Nanomaterials. 11:2892021. View Article : Google Scholar : PubMed/NCBI

10 

He Z, Chen Q, Chen F, Zhang J, Li H and Lin JM: DNA-mediated cell surface engineering for multiplexed glycan profiling using MALDI-TOF mass spectrometry. Chem Sci. 7:5448–5452. 2016. View Article : Google Scholar

11 

Cavada BS, Pinto-Junior VR, Osterne VJ and Nascimento KS: ConA-like lectins: High similarity proteins as models to study structure/biological activities relationships. Int J Mol Sci. 20:302018. View Article : Google Scholar

12 

Lei HY and Chang CP: Lectin of Concanavalin A as an anti-hepatoma therapeutic agent. J Biomed Sci. 16:102009. View Article : Google Scholar

13 

Lai YC, Chuang YC, Chang CP and Yeh TM: Macrophage migration inhibitory factor has a permissive role in concanavalin A-induced cell death of human hepatoma cells through autophagy. Cell Death Dis. 6:e20082015. View Article : Google Scholar : PubMed/NCBI

14 

Chang CP, Yang MC, Liu HS, Lin YS and Lei HY: Concanavalin A induces autophagy in hepatoma cells and has a therapeutic effect in a murine in situ hepatoma model. Hepatology. 45:286–296. 2007. View Article : Google Scholar : PubMed/NCBI

15 

Lai AC, Chi PY, Thio CL, Han YC, Kao HN, Hsieh HW, Gervay-Hague J and Chang YJ: α-lactosylceramide protects against iNKT-mediated murine airway hyperreactivity and liver injury through competitive inhibition of Cd1d binding. Front Chem. 7:8112019. View Article : Google Scholar : PubMed/NCBI

16 

Li S, Bi Y, Wang Q, Xu M, Ma Z, Yang Y, Chang Y, Chen S, Liu D, Duan Z, et al: Transplanted mouse liver stem cells at different stages of differentiation ameliorate concanavalin A-induced acute liver injury by modulating tregs and Th17 cells in mice. Am J Trans Res. 11:7324–7337. 2019.

17 

Luo G, Chao YL, Tang B, Li BS, Xiao YF, Xie R, Wang SM, Wu YY, Dong H, Liu XD and Yang SM: miR-149 represses metastasis of hepatocellular carcinoma by targeting actin-regulatory proteins PPM1F. Oncotarget. 6:37808–37823. 2015. View Article : Google Scholar

18 

Zhang Y, Hu MY, Wu WZ, Wang ZJ, Zhou K, Zha XL and Liu KD: The membrane-cytoskeleton organizer ezrin is necessary for hepatocellular carcinoma cell growth and invasiveness. J Cancer Res Clin Oncol. 132:685–697. 2006. View Article : Google Scholar

19 

Yang LN, Ning ZY, Wang L, Yan X and Meng ZQ: HSF2 regulates aerobic glycolysis by suppression of FBP1 in hepatocellular carcinoma. Am J Cancer Res. 9:1607–1621. 2019.PubMed/NCBI

20 

Liu Y, Zhang Y, Xiao B, Tang N, Hu J, Liang S, Pang Y, Xu H, Ao J, Yang J, et al: MiR-103a promotes tumour growth and influences glucose metabolism in hepatocellular carcinoma. Cell Death Dis. 12:6182021. View Article : Google Scholar : PubMed/NCBI

21 

Du P, Liang H, Fu X, Wu P, Wang C, Chen H, Zheng B, Zhang J, Hu S, Zeng R, et al: SLC25A22 promotes proliferation and metastasis by activating MAPK/ERK pathway in gallbladder cancer. Cancer Cell Int. 19:332019. View Article : Google Scholar

22 

Chen J, Ji T, Wu D, Jiang S, Zhao J, Lin H and Cai X: Human mesenchymal stem cells promote tumor growth via MAPK pathway and metastasis by epithelial mesenchymal transition and integrin α5 in hepatocellular carcinoma. Cell Death Dis. 10:4252019. View Article : Google Scholar : PubMed/NCBI

23 

Zhang YP, Liu KL, Yang Z, Lu BS, Qi JC, Han ZW, Yin YW, Zhang M, Chen DM, Wang XW, et al: The involvement of FBP1 in prostate cancer cell epithelial mesenchymal transition, invasion and metastasis by regulating the MAPK signaling pathway. Cell Cycle. 18:2432–2446. 2019. View Article : Google Scholar : PubMed/NCBI

24 

Liu T, Wu L, Wang D, Wang H, Chen J, Yang C, Bao J and Wu C: Role of reactive oxygen species-mediated MAPK and NF-κB activation in polygonatum cyrtonema lectin-induced apoptosis and autophagy in human lung adenocarcinoma A549 cells. J Biochem. 160:315–324. 2016. View Article : Google Scholar : PubMed/NCBI

25 

Zhang X, Xu L and Yang T: miR-31 modulates liver cancer HepG2 cell apoptosis and invasion via ROCK1/F-actin pathways. OncoTargets Ther. 13:877–888. 2020. View Article : Google Scholar

26 

Schneiderman RS, Giladi M, Zeevi E, Voloshin T, Shteingauz A, Porat Y, Munster M, Kirson E, Weinberg U and Palti Y: Angi-11. tumor treating fields (ttfields) inhibit cancer cell migration and invasion by inducing reorganization of the actin cytoskeleton and formation of cell adhesions. Neuro Oncol. 20 (Suppl 6):vi302018. View Article : Google Scholar

27 

Gkretsi V and Stylianopoulos T: Cell adhesion and matrix stiffness: Coordinating cancer cell invasion and metastasis. Front Oncol. 8:1452018. View Article : Google Scholar

28 

Rudzka DA, Mason S, Neilson M, McGarry L, Kalna G, Hedley A, Blyth K and Olson MF: Selection of established tumour cells through narrow diameter micropores enriches for elevated Ras/Raf/MEK/ERK MAPK signalling and enhanced tumour growth. Small GTPases. 12:294–310. 2020. View Article : Google Scholar : PubMed/NCBI

29 

Ni Y, Wang X, Yin X, Li Y, Liu X, Wang H, Liu X, Zhang J, Gao H, Shi B and Zhao S: Plectin protects podocytes from adriamycin-induced apoptosis and F-actin cytoskeletal disruption through the integrin α6β4/FAK/p38 MAPK pathway. J Cell Mol Med. 22:5450–5467. 2018. View Article : Google Scholar : PubMed/NCBI

30 

Kwon Y, Park SJ, Nguyen BT, Kim MJ, Oh S, Lee H, Park N, Kim HS, Kang MJ, Min BS, et al: Multi-layered proteogenomic analysis unravels cancer metastasis directed by MMP-2 and focal adhesion kinase signaling. Sci Rep. 11:171302021. View Article : Google Scholar : PubMed/NCBI

31 

Lu J, Wang Z, Li S, Xin Q, Yuan M, Li H, Song X, Gao H, Pervaiz N, Sun X, et al: Quercetin inhibits the migration and invasion of HCCLM3 cells by suppressing the expression of p-Akt1, matrix metalloproteinase (MMP) MMP-2, and MMP-9. Med Sci Monit. 24:2583–2589. 2018. View Article : Google Scholar

32 

Jian Q, Yang Z, Shu J, Liu XW, Zhang J and Zheng L: Lectin BS-I inhibits cell migration and invasion via AKT/GSK-3β/β-catenin pathway in hepatocellular carcinoma. J Cell Mol Med. 22:315–329. 2018. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Jiang H, Wen X, Zhang X and Zhang B: Concanavalin A inhibits human liver cancer cell migration by regulating F‑actin redistribution and assembly via MAPK signaling pathway. Oncol Lett 24: 405, 2022.
APA
Jiang, H., Wen, X., Zhang, X., & Zhang, B. (2022). Concanavalin A inhibits human liver cancer cell migration by regulating F‑actin redistribution and assembly via MAPK signaling pathway. Oncology Letters, 24, 405. https://doi.org/10.3892/ol.2022.13525
MLA
Jiang, H., Wen, X., Zhang, X., Zhang, B."Concanavalin A inhibits human liver cancer cell migration by regulating F‑actin redistribution and assembly via MAPK signaling pathway". Oncology Letters 24.5 (2022): 405.
Chicago
Jiang, H., Wen, X., Zhang, X., Zhang, B."Concanavalin A inhibits human liver cancer cell migration by regulating F‑actin redistribution and assembly via MAPK signaling pathway". Oncology Letters 24, no. 5 (2022): 405. https://doi.org/10.3892/ol.2022.13525
Copy and paste a formatted citation
x
Spandidos Publications style
Jiang H, Wen X, Zhang X and Zhang B: Concanavalin A inhibits human liver cancer cell migration by regulating F‑actin redistribution and assembly via MAPK signaling pathway. Oncol Lett 24: 405, 2022.
APA
Jiang, H., Wen, X., Zhang, X., & Zhang, B. (2022). Concanavalin A inhibits human liver cancer cell migration by regulating F‑actin redistribution and assembly via MAPK signaling pathway. Oncology Letters, 24, 405. https://doi.org/10.3892/ol.2022.13525
MLA
Jiang, H., Wen, X., Zhang, X., Zhang, B."Concanavalin A inhibits human liver cancer cell migration by regulating F‑actin redistribution and assembly via MAPK signaling pathway". Oncology Letters 24.5 (2022): 405.
Chicago
Jiang, H., Wen, X., Zhang, X., Zhang, B."Concanavalin A inhibits human liver cancer cell migration by regulating F‑actin redistribution and assembly via MAPK signaling pathway". Oncology Letters 24, no. 5 (2022): 405. https://doi.org/10.3892/ol.2022.13525
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team